| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2004 | WO2003082255A3 Use of mob-5 in pain |
| 02/05/2004 | WO2003082247A3 Drug microparticles |
| 02/05/2004 | WO2003082195A9 Protamine-adenoviral vector complexes and methods of use |
| 02/05/2004 | WO2003074654A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 02/05/2004 | WO2003073994A3 Methods of treating nerve entrapment syndromes |
| 02/05/2004 | WO2003072735A3 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 02/05/2004 | WO2003072034A3 Cyclic peptides and analogs useful to treat allergies |
| 02/05/2004 | WO2003070917A3 Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways |
| 02/05/2004 | WO2003070167A3 Therapeutic and prophylactic treatment of aging and disorders of aging in humans |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003064593A3 Antigen panels and methods of using the same |
| 02/05/2004 | WO2003064455A3 Macrocyclic peptides active against the hepatitis c virus |
| 02/05/2004 | WO2003061622A3 Method and device for feeding living cells into a biological body fluid |
| 02/05/2004 | WO2003059287A3 Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution |
| 02/05/2004 | WO2003059272A3 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003053459A3 Differential induction, maintenance and regulation of cd8+ t cell response against a model antigen expressed by an acute versus a chronic intracellular bacterium |
| 02/05/2004 | WO2003048390A8 A process for the preparation of a non-toxic anthrax vaccine |
| 02/05/2004 | WO2003046137A3 Hiv envelope v3-ccr5 binding site immunogen |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2003040304A3 Method of proliferation in neurogenic regions |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003031605A3 Human gtpase involved in chronic obstructive pulmonary disease (copd) |
| 02/05/2004 | WO2003024354A3 Interleukin-12 as a veterinary vaccine adjuvant |
| 02/05/2004 | WO2003016915A8 Tumor specific oligosaccharide sequences and use thereof |
| 02/05/2004 | WO2003006603A3 Triple polypeptide complexes |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | WO2002094378A3 Increased functional activity and/or expression of abc transporters protects against the loss of dopamine neurons associated with parkinson's disease |
| 02/05/2004 | WO2002072776A3 Cell culture system for synthesis of infectious hepatitis c virus |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 02/05/2004 | US20040025195 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
| 02/05/2004 | US20040025194 Beta chain-associated regulator of apoptosis |
| 02/05/2004 | US20040024725 Regulated apoptosis |
| 02/05/2004 | US20040024363 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 02/05/2004 | US20040024220 Lipids |
| 02/05/2004 | US20040024192 19 human secreted proteins |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024188 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 02/05/2004 | US20040024187 Comprises receptor polypeptide associated with energy balance for diagnosis and treatment of arteriolosclerosis and inflammatory disorders |
| 02/05/2004 | US20040024185 NF-AT-interacting protein NIP45 and methods of use therefor |
| 02/05/2004 | US20040024181 Comprises polypeptide for treatment, diagnosis, and prevention of cancer, inflammation, nervous system disorders, learning and memory defects and sexual disorders |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024065 Novel metabolic targets and markers |
| 02/05/2004 | US20040024064 Determining risk for developing a fat metabolism disorder by comparing a sample Gs alpha expression level with that of the normal level; treating the disorder with a nucleic acid that codes a Gs alpha protein; prognosis; diagnosis; |
| 02/05/2004 | US20040023974 Pharmacological agents which are inhibitors of PTPases, in particular, the compounds of formula I inhibit PTP-1B and TC PTP, and thus may be employed for the treatment of conditions associated with PTPase activity. The compounds of the present |
| 02/05/2004 | US20040023949 Reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of- function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient |
| 02/05/2004 | US20040023934 Method of treating prostatic diseases using active vitamin D analogues |
| 02/05/2004 | US20040023931 Method for maintaining a healthy bone structure by administering to a patient a bone health promoting effective amount of a medicament containing 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic |
| 02/05/2004 | US20040023918 Antisense modulation of inhibitor-kappa B kinase-gamma expression |
| 02/05/2004 | US20040023917 Treatment of asthma with oligonucleotides which specifically hybridize with nucleic acids encoding B7 proteins. |
| 02/05/2004 | US20040023910 Methods of inhibiting uterine leiomyoma proliferation and preventing formation of uterine leiomyomas, compounds and compositions that stimulate induction of the Cyr61 gene and compounds that increase Cyr61 activity. |
| 02/05/2004 | US20040023909 Process for preventing or reducing undesirable immunological effects to infectious agents in subjects |
| 02/05/2004 | US20040023908 Antisense modulation of a20 expression |
| 02/05/2004 | US20040023905 Antisense modulation of LAR expression |
| 02/05/2004 | US20040023904 Antisense modulation of PTPRA expression |
| 02/05/2004 | US20040023888 Retinol derivatives, the method of preparations and the uses thereof |
| 02/05/2004 | US20040023886 Method for treating neurological conditions and inducing immunosuppression with cephaibols |
| 02/05/2004 | US20040023885 Islet neogenesis therapy comprising an EGF and a gastrin in combination with immune suppression, and for treating or preventing early stage diabetes with a gastrin/CCK receptor ligand and an immunosuppressant are provided |
| 02/05/2004 | US20040023884 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 02/05/2004 | US20040023883 IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
| 02/05/2004 | US20040023881 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 02/05/2004 | US20040023880 Methods of inducing formation of functional and organized lymphatic vessels |
| 02/05/2004 | US20040023879 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2004 | US20040023878 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
| 02/05/2004 | US20040023877 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 02/05/2004 | US20040023874 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/05/2004 | US20040023873 A novel protein, enkurin, that is preferentially expressed in sperm has been discovered. Enkurin binds to TRPCs including TRPC2-S, a protein encoded by TRPC2 that is not predicted to be a calcium channel subunit. The invention includes methods |
| 02/05/2004 | US20040023872 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 02/05/2004 | US20040023871 Treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels. |
| 02/05/2004 | US20040023869 Interleukin-1 inhibitors in the treatment of diseases |
| 02/05/2004 | US20040023868 Directed to compositions comprising nisin and sublancin in amounts that are effective to inhibit bacterial spore germination. Additionally, the present invention is directed towards methods of inhibiting bacterial spore germination for |
| 02/05/2004 | US20040023867 Methods and compositions for treating benign gynecological disorders |
| 02/05/2004 | US20040023866 Isolated Bcl-2 domain-containing polypeptides from Mycobacterial species, including M. tuberculosis, M. avium, M. bovis, M. leprae and M. smegmatis, and from Streptomyces species, including S. coelicolor, as well as modifications of |
| 02/05/2004 | US20040023865 Polypeptides that contain at least one antigenic portion of a B. microti antigen and DNA sequences encoding such polypeptides. Antigenic epitopes of such antigens are also provided, together with pharmaceutical compositions and |
| 02/05/2004 | US20040023864 Novel activity in regulating angiogenesis. New variant Ryk proteins were constructed that were useful in modulating the capillary forming activity of endothelial cells. Variant Ryk proteins, may be employed as therpeutics in diseases such as |
| 02/05/2004 | US20040023863 Multi-tier approach to the administration of growth factor proteins in the treatment of heart disease. Also disclosed is a method to evaluate the effectiveness of the administration of growth factor proteins comprising the clinical assay of |
| 02/05/2004 | US20040023862 Newly identified uses of BRS3 polypeptides and polynucleotides encoding such polypeptides, to their use in therapy of ischemia, of neurodegenerative diseases, of memory and attention disorders, and in identifying compounds which may be |
| 02/05/2004 | US20040023861 Isolated cysteinyl leukotriene receptor polypeptide comprising amino acid sequence of SEQ ID NO: 2 or variant thereof which is capable of binding a leukotriene; or fragment of (i) or (ii) which is capable of binding a leukotriene. |
| 02/05/2004 | US20040023860 Methods and compositions for inhibiting neoplastic cell growth |
| 02/05/2004 | US20040023859 New melanocortin receptor ligands are cyclic peptide analogs that preferably exhibit selectivity for the MC-4 and/or the MC-3 receptors relative to the other melanocortin receptors |
| 02/05/2004 | US20040023858 Antifungal combination therapy |
| 02/05/2004 | US20040023857 Treatment of rosacea |
| 02/05/2004 | US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein. |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023853 Treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided they are antagonist peptides |
| 02/05/2004 | US20040023851 Method for the porduction of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross- linking in the presence of chemically non- reacting effectors of the oxygen affinity of the haemoglobin |
| 02/05/2004 | US20040023850 System for providing in vivo delivery of molecules or complexes to extravascular mammalian cells using an intravascular administration route. The molecules or complexes are inserted in an injection solution into a mammalian |
| 02/05/2004 | US20040023846 Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith |
| 02/05/2004 | US20040023840 Combination of organic compounds |
| 02/05/2004 | US20040023390 Using small interfering RNA sequences for treating neurodegenerative diseases; gene expression inhibition |
| 02/05/2004 | US20040023386 Modulation of nitric oxide synthase by PKC |
| 02/05/2004 | US20040023385 Comprises oligonucleotides for gene expression inhibition of requiem apoptosis zinc finger gene (REQUIEM) and treatment of cancer, aberrant apoptosis and developmental disorders |
| 02/05/2004 | US20040023384 Antisense modulation of G protein-coupled receptor 12 expression |
| 02/05/2004 | US20040023379 Comprises oligonucleotides for gene expression inhibition of hepatoma derived growth factor (HDGF) for treating cancer and metabolic disorder |
| 02/05/2004 | US20040023378 Antisense modulation of KIAA1531 protein expression |
| 02/05/2004 | US20040023373 Novel mucosal vascular addressins |
| 02/05/2004 | US20040023356 Comprise nucleotides equences coding polypeptide for use in diagnosis and treatment of bone, eye and peridontal disease |
| 02/05/2004 | US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/05/2004 | US20040023336 Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses |